Overview

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

Status:
RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to just below the knee. Participation may last up to 30 weeks including screening.
Phase:
PHASE2
Details
Lead Sponsor:
Eli Lilly and Company